After finding out about successful trials showing promising effects of intranasal intermediate-acting regular insulin for Mild Cognitive Impairment and Alzheimer's Disease, Claxton et al. performed an RCT to investigate whether the long-acting insulin detemir improves cognition in adults with these disorders. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.